Sort
48,018 grants matching “immunotherapy”
Moving Forward with Multiple Myeloma
$657,844Melinda R Stolley · Medical College Of Wisconsin · R01 · FY2025 · CA
Generation of tumor specific immunity in canine osteosarcoma through dendritic cell hyperactivation
$657,791Cheryl A London · Tufts University Boston · U01 · FY2023 · CA
Mechanisms of immune homeostasis and regulation of intraocular inflammation
$657,780Charles E Egwuagu · National Eye Institute · ZIA · FY2021 · EY
Non-deletional CD8+ T cell tolerance
$657,673Stephen C Jameson · University Of Minnesota · R01 · FY2025 · AI
Targeting head and neck cancer cells and the adverse tumor microenvironment with a novel small-molecule STAT3 inhibitor
$657,573David John Tweardy · University Of Tx Md Anderson Can Ctr · R01 · FY2023 · CA
Cytokines in AIDS and Cancer
$657,412George N. Pavlakis · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
The Variation of the NK Cell Receptome in Pemphigus
$657,388Danillo G Augusto · University Of North Carolina Charlotte · R01 · FY2024 · AI
Using genetically engineered mouse models of brain tumors to develop therapeutic nanoparticles & biomaterials
$657,360Eric C Holland · Fred Hutchinson Cancer Research Center · R01 · FY2016 · CA
FAST-FNA immune cell profiling in HNSCC
$657,310Ralph Weissleder · Massachusetts General Hospital · R01 · FY2022 · CA
FAST-FNA immune cell profiling in HNSCC
$657,310Ralph Weissleder · Massachusetts General Hospital · R01 · FY2023 · CA
An Investigation of the Molecular Mechanisms for and Prediction of the Severity of Cancer Chemotherapy-Related Fatigue Using a Multi-staged Integrated Omics Approach
$657,307Kord Michael Kober · University Of California, San Francisco · R37 · FY2025 · CA
Molecular Determinants and Therapeutic Consequences of Immune Heterogeneity in Cancer
$657,258Robert H Vonderheide · University Of Pennsylvania · R01 · FY2021 · CA
Project 3: Spherical Nucleic Acids as Immunotherapeutic Agents for Prostate Cancer
$657,226Chad A. Mirkin · Northwestern University At Chicago · U54 · FY2016 · CA
Chemokine-mediated antigen-specific T cell responses and immunotherapies to treat head and neck cancer
$657,132Dohun Pyeon · Michigan State University · R01 · FY2021 · DE
Remodeling the Immune Landscape in Breast Cancer Leptomeningeal Disease Using Dendritic Cell Therapy is an Effective Treatment and Protects Against Disease Recurrence.
$657,121Peter Alexander Forsyth · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2025 · CA
Integrating patient-reported outcomes and T-cell receptor sequencing to predict immune-related adverse events
$657,119Aung Naing · University Of Tx Md Anderson Can Ctr · R01 · FY2024 · CA
Integrating patient-reported outcomes and T-cell receptor sequencing to predict immune-related adverse events
$657,119Aung Naing · University Of Tx Md Anderson Can Ctr · R01 · FY2025 · CA
Mechanisms of JAG1-mediated immune suppression in the pancreatic cancer microenvironment
$657,074Lan Zhou · Methodist Hospital Research Institute · R01 · FY2025 · CA
Cancer Therapy Clinical Trials Using Novel Recombinant Vaccines
$657,066James L. Gulley · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Clinical trials employing cancer vaccine combination therapies
$657,066James L. Gulley · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Genetically engineered mouse model to improve therapy of NUT carcinoma
$657,032Christopher A French · Brigham And Women'S Hospital · R01 · FY2025 · CA
Immune Signatures and Clinical Outcomes in Acute Pancreatitis
$656,955Georgios I Papachristou · Ohio State University · R01 · FY2024 · DK
3D Microscopy with Ultraviolet Surface Excitation (3D-MUSE)
$656,893David L Wilson · Case Western Reserve University · R01 · FY2023 · EB
Integrating Epigenetic Modulation into DNA Damage Repair
$656,890Pamela N Munster · University Of California, San Francisco · R01 · FY2022 · CA
Exploiting the Mechanobiology of PD-1 for Cancer Immunotherapy
$656,845Cheng Zhu · Georgia Institute Of Technology · U01 · FY2020 · CA